Enable job alerts via email!
A prestigious NHS healthcare provider is seeking a Clinical Fellow (ST3+) in Haematology Early Phase Clinical Trials starting February 2026. This full-time position offers comprehensive training in running clinical trials, including protocol development and regulatory documentation. Candidates must possess MRCP or equivalent and have competency in chemotherapy prescribing. The role is based in London and involves engaging in translational research linked to drug development.
Clinical Fellow (ST3+) in Haematology Early Phase Clinical Trials at University College London Hospitals NHS Foundation Trust. Applications are invited for a position starting February 2026. The aim of this post is to offer comprehensive specialist training in all aspects of running early phase haematology clinical trials, including protocol development, regulatory procedures, translational research projects and presentation of research at meetings. This is a full-time, fixed-term post for a period of 12 months.
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services and are committed to sustainable practice with targets for net zero emissions.
UCLH provides services across eight sites, including:
*In the most recent NHS staff survey, UCLH was recognised as a leading place to work. For more information, please refer to the attached job description and UCLH recruitment pages.
Advert closes on 29 September 2025. For the full Person Specification and the main responsibilities of this role, please refer to the attached Job Description.